Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Neuroimmunologic investigations of autism spectrum disorders (ASD)  

Neuroimmunologic conditions in regressed autistic children will be addressed using two independent studies. The first study will identify neuroimmune abnormalaties by measuring a variety of phenotypes over time. These abnormalities will be expected to be absent in the control group. The second study will address the effect of minocline treatment on cytokine and chemokine patterns in regressed autistic children. Project Status
ONGOING

2010

Funder National Institutes of Health
Fiscal Year Funding $385,337.00
Current Award Period Ongoing
Project Number 1ZIAMH002915-03
Principal Investigator Swedo, Susan
Received ARRA Funding? No
Strategic Plan Question Question 2: How Can I Understand What Is Happening? (Biology)
Subcategory Immune/Metabolic Pathways
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 2SF. Launch two studies that focus on prospective characterization of children with reported regression to investigate potential risk factors by 2012. IACC Recommended Budget: $4,500,000 over 5 years.
Federal or Private? Federal
Institution National Institutes of Health
State/Country Maryland
Web Link 1 Neuroimmunologic investigations of autism spectrum disorders (ASD) (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
New! History/Related Projects Neuroimmunologic investigations of autism spectrum disorders (ASD) | $348,146.00 | 2009 | 1ZIAMH002915-02
Neuroimmunologic investigations of autism spectrum disorders (ASD) | $512,425.00 | 2008 | Z01MH002915-01